FutureWiseResearch: Global Market Research Reports, USA, UK

Overview

Ablation Devices Market Overview:

According to FutureWise analysis, the market for ablation devices is projected to expand at a CAGR of 12% from 2023-2031.

The ablation therapies are used for treating different diseases like cancer, gynaecological diseases, ophthalmic diseases and cardiovascular diseases. It is less painful than traditional surgeries as it a minimally invasive process resulting in the reduction of recovery times. Additionally, it causes less damage to the tissues surrounding the affected area. Although it lowers the side effects, it has certain disadvantages like ablation devices cannot treat bulky and large tissues like neck and bone nodules and these devices are not available in remote locations. Furthermore, the rising prevalence of patients with cardiovascular diseases in developed countries like the United States shall boost the ablation devices market growth. According to a data provided by St. Jude Medical Inc., over 240,000 catheter ablations were performed in the United States while over 980,000 patients were treated using ablation devices across the world. Moreover, the increased prevalence of cancer shall propel the market growth. As per the WHO, the number of newly registered cases are predicted to rise by over 65% in twenty years. Such an escalating prevalence of chronic diseases shall contribute to the proliferation of the market.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Ablation Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Ablation Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Ablation Devices Market:

St. Jude Medical Inc.
Medtronic plc
Boston Scientific Corporation
AngioDynamics, Inc.
AtriCure, Inc.
Conmed Corporation
Olympus Corporation
Smith and Nephew plc
BTG plc
Johnson and Johnson
Accuray Incorporated
C.R. Bard, Inc.
Varian Medical Systems, Inc.
Elekta AB
Misonix, Inc.
Hologic, Inc.
Stryker Corporation
EDAP TMS S.A.
Japan Lifeline Co., Ltd.
Halyard Health, Inc.
Merit Medical Systems, Inc.
Integra LifeSciences Holdings Corporation
Abbott Laboratories
Terumo Corporation.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Ablation Devices Market Segmentation:

By Technology

Thermal Ablation
- Electrical
  - Electrical Ablators
    - Argon Plasma/Beam Coagulator
    - Irreversible Electroporation
  - Electronic Brachytherapy
- Radiation
  - Brachytherapy
    - High-Dose-Rate Brachytherapy
    - Pulsed-Dose-Rate Brachytherapy
    - Permanent Seed Brachytherapy
  - Stereotactic Radiotherapy and Radiosurgery
  - Stereotactic Body Radiation
  - Image Guided Radiation Therapy
  - Intensity Modulated Radiation Therapy
  - Proton Beam Therapy
- Radiofrequency
  - Temperature Controlled
  - Fluid Cooled
  - Catheter Manipulation Systems
- Light
  - Cold Lasers
  - Excimer Lasers
- Ultrasound
  - High Intensity Focused Ultrasound (HIFU)
  - Magnetic Resonance Imaging-Guided Focused Ultrasound (MRI-FUS)
  - Ultrasonic Surgical Systems
  - Shock Wave Lithotripsy
- Microwave
- Hydrothermal
Non-Thermal Ablation
- Cryoablation
  - Tissue Contact Probe
  - Cryogen Spray Probe
  - Epidermal and Subcutaneous Cryoablation Devices
- Hydromechanical Ablation

By Application

Cancer
Cardiovascular
Ophthalmology
Gynecology
Urology
Orthopedics
Others

By Procedure

Aesthetics-Skin Rejuvenation and Tightening
Aesthetics-Body Sculpting, Fat Reduction, And The Reduction in The Appearance of Cellulite
Benign Prostatic Hyperplasia
Transurethral Needle Ablation
Laser and Other Energy-Based Therapies/Holmium Laser Ablation/Enucleation Of The Prostate
Stress Urinary Incontinence
Menorrhagia/Endometrial Ablation
Uterine Fibroids
Spinal Decompression and Denervation
Varicose Veins
Atrial Fibrillation
Tumor Ablation
Others

By Function

Automated/Robotic
Conventional

By Region

North America
Europe
Asia-Pacific
Latin America
Middle East and Africa

The North America region is expected to lead the market during the forecasted timeframe owing to a strong presence of major market players in the region. Furthermore, unhealthy dietary habits, lack of exercise and rising geriatric population has increased the number of patients diagnosed with cardiovascular diseases in the region. Many key players and even emerging companies have focussed on increasing their research and development activities in the region.

Competitive Landscape:

Tier 1 players- established companies in the market with a major market share
Tier 2 players
Emerging players which are growing rapidly
New Entrant

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key market trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the global ablation devices market By Technology, By Application, By Procedure, By Function and By Region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

1. Market Introduction
- 1. Objectives of the Study
  2. Market Definition
  3. Market Scope
  3.1. Years Considered for the Study
  3.2. Market Covered
  4. Currency
  5. Limitations
  6. Stakeholders
2. Research Methodology
- 1. Research Data
  1.1. Secondary Data
  1.1.1. Key Data from Secondary Sources
  1.2. Primary Data
  1.2.1. Key Data from Primary Sources
  2. Market Size Estimation
  3. Market Breakdown and Data Triangulation
  4. Assumptions for the Study
3. Executive Summary
- 1. Market Outlook
  2. Segment Outlook
  3. Competitive Insights
4. Ablation Devices Market Variables, Trends and Scope
- 1. Market Lineage Outlook
  2. Penetration and Growth Prospect Mapping
  3. Industry Value Chain Analysis
  4. Cost Analysis Breakdown
  5. Technology Overview
  6. Regulatory Framework
  6.1. Reimbursement Framework
  6.2. Standards and Compliances
5. Market Overview
- 1. Market Dynamics
  1.1. Market Driver Analysis
  1.1.1. Increasing focus of Ablation Devices Market Companies on Brand Protection
  1.1.2. Untapped Opportunities in Emerging Regions
  1.2. Market Restraint Analysis
  1.2.1. High Cost Associated with Implementation of Predictive Analysis
  1.3. Industry Challenges
  1.3.1. Presence of Ambiguous Regulatory Framework
6. Ablation Devices Market Analysis Tools
- 1. Industry Analysis - Porter’s
  1.1. Supplier Power
  1.2. Buyer Power
  1.3. Substitution Threat
  1.4. Threat from New Entrants
  1.5. Competitive Rivalry
  2. Pestel Analysis
  2.1. Political Landscape
  2.2. Environmental Landscape
  2.3. Social Landscape
  2.4. Technology Landscape
  2.5. Legal Landscape
  3. Major Deals And Strategic Alliances Analysis
  3.1. Joint Ventures
  3.2. Mergers and Acquisitions
  3.3. Licensing and Partnership
  3.4. Technology Collaborations
  3.5. Strategic Divestments
  4. Market Entry Strategies
  5. Case Studies
7. Ablation Devices Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Thermal Ablation
  1.1. Electrical
  1.1.1. Electrical Ablators
  1.1.1.1. Argon Plasma/Beam Coagulator
  1.1.1.2. Irreversible Electroporation
  1.1.2. Electronic Brachytherapy
  1.2. Radiation
  1.2.1. Brachytherapy
  1.2.1.1. High-Dose-Rate Brachytherapy
  1.2.1.2. Pulsed-Dose-Rate Brachytherapy
  1.2.1.3. Permanent Seed Brachytherapy
  1.2.2. Stereotactic Radiotherapy and Radiosurgery
  1.2.3. Stereotactic Body Radiation
  1.2.4. Image Guided Radiation Therapy
  1.2.5. Intensity Modulated Radiation Therapy
  1.2.6. Proton Beam Therapy
  1.3. Radiofrequency
  1.3.1. Temperature Controlled
  1.3.2. Fluid Cooled
  1.3.3. Catheter Manipulation Systems
  1.4. Light
  1.4.1. Cold Lasers
  1.4.2. Excimer Lasers
  1.5. Ultrasound
  1.5.1. High Intensity Focused Ultrasound (HIFU)
  1.5.2. Magnetic Resonance Imaging-Guided Focused Ultrasound (MRI-FUS)
  1.5.3. Ultrasonic Surgical Systems
  1.5.4. Shock Wave Lithotripsy
  1.6. Microwave
  1.7. Hydrothermal
  2. Non-Thermal Ablation
  2.1. Cryoablation
  2.1.1. Tissue Contact Probe
  2.1.2. Cryogen Spray Probe
  2.1.3. Epidermal and Subcutaneous Cryoablation Devices
  2.2. Hydromechanical Ablation
8. Ablation Devices Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Cancer
  2. Cardiovascular
  3. Ophthalmology
  4. Gynecology
  5. Urology
  6. Orthopedics
  7. Others
9. Ablation Devices Market, By Procedure Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Aesthetics-Skin Rejuvenation and Tightening
  2. Aesthetics-Body Sculpting, Fat Reduction, And The Reduction in The Appearance of Cellulite
  3. Benign Prostatic Hyperplasia
  4. Transurethral Needle Ablation
  5. Laser and Other Energy-Based Therapies/Holmium Laser Ablation/Enucleation Of The Prostate
  6. Stress Urinary Incontinence
  7. Menorrhagia/Endometrial Ablation
  8. Uterine Fibroids
  9. Spinal Decompression and Denervation
  10. Varicose Veins
  11. Atrial Fibrillation
  12. Tumor Ablation
  13. Others
10. Ablation Devices Market, By Function Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Automated/Robotic
  2. Conventional
11. North America Ablation Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. U.S.A
  2.2. Canada
  2.3. Mexico
  3. Market Size (USD Million) Forecast for North America 2023-2031
12. Latin America Ablation Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Brazil
  2.2. Venezuela
  2.3. Argentina
  2.4. Rest of Latin America
  3. Market Size (USD Million) Forecast for Latin America 2023-2031
13. Europe Ablation Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Germany
  2.2. U.K
  2.3. France
  2.4. Italy
  2.5. Spain
  2.6. Russia
  2.7. Poland
  2.8. Rest of Europe
  3. Market Size (USD Million) Forecast for Europe 2023-2031
14. Asia Pacific Ablation Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Japan
  2.2. China
  2.3. India
  2.4. Australia and New Zealand
  2.5. ASEAN
  2.6. Rest of Asia Pacific
  3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031
15. Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. GCC
  2.2. Israel
  2.3. South Africa
  2.4. Rest of MEA
  3. Market Size (USD Million) Forecast for MEA 2023-2031
16. Market Share Analysis and Competitive Landscape
- 1. Global Landscape - Key Players, Revenue and Presence
  2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
  3. Global Emerging Companies
  4. North America - Market Share Analysis and Key Regional Players
  5. Europe - Market Share Analysis and Key Regional Players
  6. Asia Pacific - Market Share Analysis and Key Regional Players
  7. Global Key Player - Growth Matrix
17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
- 1. St. Jude Medical Inc.
  1.1. Company Overview
  1.2. Product Portfolio
  1.3. SWOT Analysis
  1.4. Financial Overview
  1.5. Strategic Overview
  2. Medtronic plc
  2.1. Company Overview
  2.2. Product Portfolio
  2.3. SWOT Analysis
  2.4. Financial Overview
  2.5. Strategic Overview
  3. Boston Scientific Corporation
  3.1. Company Overview
  3.2. Product Portfolio
  3.3. SWOT Analysis
  3.4. Financial Overview
  3.5. Strategic Overview
  4. AngioDynamics, Inc.
  4.1. Company Overview
  4.2. Product Portfolio
  4.3. SWOT Analysis
  4.4. Financial Overview
  4.5. Strategic Overview
  5. AtriCure, Inc.
  5.1. Company Overview
  5.2. Product Portfolio
  5.3. SWOT Analysis
  5.4. Financial Overview
  5.5. Strategic Overview
  6. Conmed Corporation
  6.1. Company Overview
  6.2. Product Portfolio
  6.3. SWOT Analysis
  6.4. Financial Overview
  6.5. Strategic Overview
  7. Olympus Corporation
  7.1. Company Overview
  7.2. Product Portfolio
  7.3. SWOT Analysis
  7.4. Financial Overview
  7.5. Strategic Overview
  8. Smith and Nephew plc
  8.1. Company Overview
  8.2. Product Portfolio
  8.3. SWOT Analysis
  8.4. Financial Overview
  8.5. Strategic Overview
  9. BTG plc
  9.1. Company Overview
  9.2. Product Portfolio
  9.3. SWOT Analysis
  9.4. Financial Overview
  9.5. Strategic Overview
  10. Johnson and Johnson
  10.1. Company Overview
  10.2. Product Portfolio
  10.3. SWOT Analysis
  10.4. Financial Overview
  10.5. Strategic Overview
  11. Accuray Incorporated
  11.1. Company Overview
  11.2. Product Portfolio
  11.3. SWOT Analysis
  11.4. Financial Overview
  11.5. Strategic Overview
  12. C.R. Bard, Inc.
  12.1. Company Overview
  12.2. Product Portfolio
  12.3. SWOT Analysis
  12.4. Financial Overview
  12.5. Strategic Overview
  13. Varian Medical Systems, Inc.
  13.1. Company Overview
  13.2. Product Portfolio
  13.3. SWOT Analysis
  13.4. Financial Overview
  13.5. Strategic Overview
  14. Elekta AB
  14.1. Company Overview
  14.2. Product Portfolio
  14.3. SWOT Analysis
  14.4. Financial Overview
  14.5. Strategic Overview
  15. Misonix, Inc.
  15.1. Company Overview
  15.2. Product Portfolio
  15.3. SWOT Analysis
  15.4. Financial Overview
  15.5. Strategic Overview
  16. Hologic, Inc.
  16.1. Company Overview
  16.2. Product Portfolio
  16.3. SWOT Analysis
  16.4. Financial Overview
  16.5. Strategic Overview
  17. Stryker Corporation
  1. Company Overview
  2. Product Portfolio
  3. SWOT Analysis
  4. Financial Overview
  5. Strategic Overview
  18. EDAP TMS S.A.
  18.1. Company Overview
  18.2. Product Portfolio
  18.3. SWOT Analysis
  18.4. Financial Overview
  18.5. Strategic Overview
  19. Japan Lifeline Co.ltd.
  19.1. Company Overview
  19.2. Product Portfolio
  19.3. SWOT Analysis
  19.4. Financial Overview
  19.5. Strategic Overview
  20. Halyard Health, Inc.
  20.1. Company Overview
  20.2. Product Portfolio
  20.3. SWOT Analysis
  20.4. Financial Overview
  20.5. Strategic Overview
  21. Merit Medical Systems, Inc.
  21.1. Company Overview
  21.2. Product Portfolio
  21.3. SWOT Analysis
  21.4. Financial Overview
  21.5. Strategic Overview
  22. Integra LifeSciences Holdings Corporation
  22.1. Company Overview
  22.2. Product Portfolio
  22.3. SWOT Analysis
  22.4. Financial Overview
  22.5. Strategic Overview
  23. Abbott Laboratories
  23.1. Company Overview
  23.2. Product Portfolio
  23.3. SWOT Analysis
  23.4. Financial Overview
  23.5. Strategic Overview
  24. Terumo Corporation
  24.1. Company Overview
  24.2. Product Portfolio
  24.3. SWOT Analysis
  24.5. Strategic Overview
18. Pre and Post COVID-19 Impact
- 1. Positive influence on the healthcare industry
  2. The financial disruption of the manufacturing sector
  3. Impact of COVID-19 on emerging companies
  4. Significant mandates in the healthcare regulations initiated by administrations
  5. The overall economic slowdown of the developing and developed nations
19. FutureWise SME Key Takeaway Points for Client

Data Pack license: Data Pack license: $1850

Single user license: Single user license: $4250

Multi user license: Multi user license: $5450

Corporate license: Corporate license: $7800

Ask for Discount

Buy Now

Customize This Report

Partner

Report Overview

Table of Contents

List of Tables

List of figures

Overview

Table of Contents

Report Overview

Table of Contents

List of Tables

List of figures

Need Assistance

What you get

What's included

Our Clients